Cedars-Sinai Medical Center Physicians And Scientists Present Findings At Annual Meeting Of The Pediatric Academic Societies

and often leads to septic shock. More than 20,000 people in the United States die each year from septic shock resulting from Gram-negative septicemia.

Gram-negative bacteria contain a toxin, called lipopolysaccharide (LPS) or endotoxin, on their outer membranes. Even tiny amounts of endotoxin shed from the bacteria into the blood are recognized by the immune system, which activates various types of cells, including white blood cells that produce inflammatory molecules called cytokines. Cytokines destroy invading pathogens but if the production of cytokines continues unchecked, they actually become toxic themselves. Patients suffering from septicemia who progress to septic shock actually may die as a result of the excessive immune response rather than from the initial bacterial infection alone.

In this study, headed by Dr. Arditi and involving researchers at Cedars-Sinai and several other institutions, scientists have for the first time identified in actual human cells a "receptor" that may be a key component of this process.

Scientists had previously discovered that a "Toll receptor" found in the cells of fruit flies and even in a number of plants is responsible for triggering the "innate" or primitive immune system to fend off invading organisms. Suspicions and evidence have been mounting over the past several years that similar "Toll-like receptors" exist in humans. In fact, five Toll-like receptors have recently been cloned and several others have been identified.

In this study using human endothelial cells (cells that line the blood vessels) and human monocytes (blood cells that are important in fighting infection), the researchers provided proof that endotoxin uses a Toll-receptor signaling pathway within human cells to induce NF-kappa B (a protein that turns on genes that make cytokines and trigger inflammatory responses). They also were able to show the presence of Toll-like receptors (TLR2 and TLR4) on the surface of the human cells. Identi

Contact: Sandra Van
Cedars-Sinai Medical Center

Page: 1 2 3 4 5 6

Related biology news :

1. Heart transplant surgeon at Cedars-Sinai specializes in implanting mechanisms that allow a defective heart to rest while awaiting a transplant
2. Study at Cedars-Sinai Medical Center investigates possible protective effects of plant compounds on the uterus
3. Cedars-Sinai medical tip sheet (b)
4. Researchers at Cedars-Sinai Medical Center to present first documentation of man-made chemical contaminants in the amniotic fluid of unborn babies
5. Cedars-Sinai Medical Center study identifies for the first time a molecular mechanism behind hormonal response to stress
6. Cedars-Sinai Medical Tip Sheet For April 15 (A)
7. Studies At Cedars-Sinai Confirm Identity Of An Elusive Receptor In Human Cells -- A Breakthrough In Understanding, Fighting Septic Shock
8. GenRISK Genetic Testing Program At Cedars-Sinai Medical Center Offers Patients New Hope In Confronting Disease
9. Cedars-Sinai Scientists Localize New Ataxia/Epilepsy Gene
10. Cedars-Sinai Tip Sheet For Dec. 21
11. Cedars-Sinai Scientist Finds Malignancy Gene In Tumor Cells

Post Your Comments:

(Date:5/28/2020)... ... May 28, 2020 , ... ... results from their 1801 Phase 1/2 study (NCT03678883, EudraCT #: 2018-003739-32) will be ... will take place virtually on May 29th, 2020. Dr. Benedito Carneiro, Brown University’s ...
(Date:5/21/2020)... ALPHARETTA, Ga. (PRWEB) , ... ... ... provider of Human Capital IntegritySM technology-based services specializing in background and medical ... with their COVID-19 return-to-work planning and keeping their workforce safe. The new ...
(Date:5/21/2020)... Ariz. (PRWEB) , ... May 20, 2020 , ... Law ... and remove danger for all of us. The positions of these men and women ... from the defense for not following rules precisely. Officers have always had to face ...
Breaking Biology News(10 mins):
(Date:5/9/2020)... ... May 08, 2020 , ... Worldwide Business with kathy ... business program on Sunday, May 10, 2020 and Wednesday, May 13, 2020 at 8:00pm ... exclusive interviews will spotlight key executives from Techolution and Bravado Pharmaceuticals ...
(Date:5/5/2020)... (PRWEB) , ... May 05, 2020 , ... ... solutions company, announced today the launch of its iGlucose® LTE Cat-M ... iGlucose solution utilizes LTE Cat-M1 technology, the industry’s newest and broadest cellular connectivity ...
(Date:4/23/2020)... ... April 22, 2020 , ... Across ... to protect themselves from COVID-19. Virginia has only been receiving 50% to 7.7% ... Association (FEMA). , As Governor Northam told the Virginia Mercury, “While we appreciate ...
(Date:4/22/2020)... (PRWEB) , ... April 21, 2020 , ... ... continue their work through COVID-19. Many clinical trial teams are working remotely and ... Ripple Science wants to help researchers continue their research during this uncertain time ...
Breaking Biology Technology:
Cached News: